Tahara; Tomoyuki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tahara; Tomoyuki.The latest application filed is for "negative-electrode material for li-ion secondary cell, method for manufacturing said material, negative electrode for li-ion-secondary-cell, and li-ion secondary cell".

Company Profile

0.12.15

Tahara; Tomoyuki - Tokyo JP
Tahara; Tomoyuki - San Diego CA
TAHARA; Tomoyuki - La Jolla CA
Tahara; Tomoyuki - Chiba JP
Tahara; Tomoyuki - Takasaki JP
Tahara; Tomoyuki - Gunma JP
Tahara; Tomoyuki - Takasaki-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Negative-electrode material for Li-ion secondary cell, method for manufacturing said material, negative electrode for Li-ion-secondary-cell, and Li-ion secondary cell Grant 10,930,929 - Tahara February 23, 2	2021-02-23
Negative-electrode Material For Li-ion Secondary Cell, Method For Manufacturing Said Material, Negative Electrode For Li-ion-secondary-cell, And Li-ion Secondary Cell App 20190081323 - Tahara; Tomoyuki	2019-03-14
Anti-CD98 antibody processes Grant 9,688,770 - Tahara , et al. June 27, 2	2017-06-27
Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same Grant 9,447,172 - Kato , et al. September 20, 2	2016-09-20
Anti-cd98 Antibody Processes App 20150307621 - TAHARA; Tomoyuki ; et al.	2015-10-29
Anti-CD98 antibody processes Grant 9,051,374 - Tahara , et al. June 9, 2	2015-06-09
METHOD FOR INCREASING DEPOSITION OF COMPLEMENT C3b ON BACTERIAL SURFACE AND PHAGOCYTOSIS BY PHAGOCYTE AND A THERAPEUTIC METHOD AND A THERAPEUTIC AGENT FOR BACTERIAL INFECTIONS App 20140212409 - KRISTIAN; Sascha ; et al.	2014-07-31
Vaccinia Virus H3l And B5r Specific Monoclonal Antibodies And Methods Of Making And Using Same App 20140186370 - KATO; SHINICHIRO ; et al.	2014-07-03
Method For Producing Lithium Iron Phosphate App 20140127111 - Tahara; Tomoyuki	2014-05-08
Anti-cd98 Antibody Processes App 20140037636 - TAHARA; Tomoyuki ; et al.	2014-02-06
Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same Grant 8,623,370 - Kato , et al. January 7, 2	2014-01-07
Anti-CD98 antibody Grant 8,486,402 - Tahara , et al. July 16, 2	2013-07-16
Interleukin 10 receptor, (IL-10R) antibodies Grant 8,420,784 - Kato , et al. April 16, 2	2013-04-16
Method For Producing Lithium Iron Phosphate App 20120292560 - Tahara; Tomoyuki ; et al.	2012-11-22
Method For Producing Lithium Iron Phosphate App 20120032119 - Tahara; Tomoyuki ; et al.	2012-02-09
Anti-cd98 Antibody App 20110280884 - TAHARA; Tomoyuki ; et al.	2011-11-17
Interleukin 10 Receptor (il-10r) Antibodies And Methods Of Use App 20110144312 - Kato; Shinichiro ; et al.	2011-06-16
Anti-CD98 antibody Grant 7,943,745 - Tahara , et al. May 17, 2	2011-05-17
Novel Anti-cd98 Antibody App 20100143367 - Tahara; Tomoyuki ; et al.	2010-06-10
Monoclonal antibody Grant 7,592,005 - Tahara September 22, 2	2009-09-22
Therapeutic agent for periodontal disease App 20070036734 - Tahara; Tomoyuki ; et al.	2007-02-15
Endothelial cell specific antibodies and uses thereof App 20070020271 - Teicher; Beverly ; et al.	2007-01-25
Novel monoclonal antibody App 20040136982 - Tahara, Tomoyuki	2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.